Management of Raynaud's phenomenon and digital ischemic lesions in scleroderma
- 1 May 2003
- journal article
- review article
- Published by Elsevier in Rheumatic Disease Clinics of North America
- Vol. 29 (2) , 293-313
- https://doi.org/10.1016/s0889-857x(03)00019-x
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Assessment of vascular function in systemic sclerosis: Indications of the development of nitrate tolerance as a result of enhanced endothelial nitric oxide productionArthritis & Rheumatism, 2002
- Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95Arthritis & Rheumatism, 2000
- Increased α2-adrenergic constriction of isolated arterioles in diffuse sclerodermaArthritis & Rheumatism, 2000
- Mechanism of Serum-Mediated Endothelial Injury in Scleroderma: Identification of a Granular Enzyme in Scleroderma Skin and SeraClinical Immunology and Immunopathology, 1997
- IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokines.Journal of Clinical Investigation, 1996
- Role of alpha‐adrenoceptor subtypes mediating sympathetic vasoconstriction in human digitsEuropean Journal of Clinical Investigation, 1988
- Morphologic Changes in the Digital Arteries of Patients with Progressive Systemic Sclerosis (Scleroderma) and Raynaud PhenomenonMedicine, 1980
- Total and Nutritional Blood Flow in the FingerClinical Science, 1972
- Survival with Systemic Sclerosis (Scleroderma)Annals of Internal Medicine, 1971
- Total and Capillary Fingertip Blood Flow in Raynaud's PhenomenonNew England Journal of Medicine, 1971